Mc Adam, LLC Bristol Myers Squibb CO Transaction History

Mc Adam, LLC

$1.77 Billion
Q3 2024

A detailed history of Mc Adam, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mc Adam, LLC holds 5,215 shares of BMY stock, worth $298,975. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,215

Holding current value

$298,975

% of portfolio

0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$39.66 - $51.75 $206,826 - $269,876	5,215 New	5,215 $269,000
Q1 2024 Apr 23, 2024	SELL	$47.98 - $54.4 $8,108 - $9,193	-169 Reduced 3.46%	4,722 $256,000
Q4 2023 Feb 05, 2024	SELL	$48.48 - $57.85 $15,755 - $18,801	-325 Reduced 6.23%	4,891 $250,000
Q3 2023 Oct 31, 2023	BUY	$57.89 - $64.73 $10,014 - $11,198	173 Added 3.43%	5,216 $302,000
Q2 2023 Aug 02, 2023	BUY	$63.71 - $70.74 $1,210 - $1,344	19 Added 0.38%	5,043 $322,000
Q1 2023 Apr 24, 2023	SELL	$65.71 - $74.53 $132,142 - $149,879	-2,011 Reduced 28.59%	5,024 $348,000
Q4 2022 Jan 27, 2023	BUY	$68.48 - $81.09 $42,594 - $50,437	622 Added 9.7%	7,035 $439,000
Q3 2022 Oct 24, 2022	SELL	$0.13 - $76.84 $45 - $26,740	-348 Reduced 5.15%	6,413 $456,000
Q2 2022 Jul 15, 2022	SELL	$72.62 - $79.98 $17,210 - $18,955	-237 Reduced 3.39%	6,761 $521,000
Q1 2022 Apr 07, 2022	SELL	$61.48 - $73.72 $2,274 - $2,727	-37 Reduced 0.53%	6,998 $511,000
Q4 2021 Jan 07, 2022	BUY	$53.63 - $62.52 $7,293 - $8,502	136 Added 1.97%	7,035 $439,000
Q3 2021 Oct 05, 2021	SELL	$59.17 - $69.31 $946 - $1,108	-16 Reduced 0.23%	6,899 $408,000
Q2 2021 Aug 02, 2021	BUY	$61.91 - $67.42 $16,282 - $17,731	263 Added 3.95%	6,915 $471,000
Q1 2021 Apr 26, 2021	BUY	$59.34 - $66.74 $39,520 - $44,448	666 Added 11.13%	6,652 $420,000
Q4 2020 Jan 12, 2021	BUY	$57.74 - $65.43 $34,817 - $39,454	603 Added 11.2%	5,986 $389,000
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $3,962 - $4,391	-69 Reduced 1.27%	5,383 $325,000
Q2 2020 Jul 31, 2020	BUY	$54.82 - $64.09 $3,892 - $4,550	71 Added 1.32%	5,452 $321,000
Q1 2020 May 08, 2020	BUY	$46.4 - $67.43 $46 - $67	1 Added 0.02%	5,381 $300,000
Q4 2019 Jan 23, 2020	BUY	$49.21 - $64.19 $264,749 - $345,342	5,380 New	5,380 $345,000
Q4 2018 Jan 30, 2019	SELL	$48.76 - $63.23 $17,748 - $23,015	-364 Closed	0 $0
Q3 2018 Oct 10, 2018	BUY	$55.19 - $62.25 $55 - $62	1 Added 0.28%	364 $23,000
Q2 2018 Aug 22, 2018	BUY	$50.53 - $62.98 $2,526 - $3,149	50 Added 15.97%	363 $20,000
Q1 2018 Apr 24, 2018	BUY	$59.92 - $68.98 $18,754 - $21,590	313 New	313 $20,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$10.8 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.1 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.33 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.47 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.5 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $122B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Adam, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Adam, LLC with notifications on news.

Account